Strategy Consultancy
Turn developments in genomics, AI and biotechnology into transformative advice and step-wise change your organisation can implement.
I connect global markets, technology, regulation and stakeholder needs with your organisation’s priorities: where to act for short-term gain, and how to build for sustainable, highly scalable, flexible long-term development.
A route from ambition to practical delivery
- Identify the strategic constraint, test opportunities and prioritise the decisions that matter now.
- Connect product, data, market positioning and stakeholder needs into a coherent direction.
- Shape lean, Agile, impactful and effective approaches, designed for highly scalable implementation.
An engagement can include a strategic review, competitor and opportunity analysis, a product or service roadmap, and prioritised recommendations, tailored to your needs.
Selected outcomes
The approach is practical: find the strategic constraint, test the opportunity and build a route from ambition to measurable delivery. It is strategy rooted in pragmatism, cost/risk analysis and a keen eye for transformational, scalable and high-impact opportunities.
- Co-authored Genomics England’s board-endorsed cancer strategy and designed a clinical-trial service from user research and pricing through to proof-of-concept pilots.
- Conceived an NLP workflow that reduced scientific annotation time from approximately 30 minutes to 30 seconds.
- At EMBL-EBI, helped reduce data-pipeline errors from around 30 to around 3 per build, recovering an estimated three to five days of developer time.
- At King’s College London, reduced annual computing costs by £20,000 while improving performance.
- More than a decade of experience translating client and stakeholder needs into analytical and technological solutions designed to remain understandable, maintainable and useful over time.
- Strong at taking novel ideas from concept to implementation without losing the science, the user or the business case.
Did you know?
In its 2020 analysis, McKinsey estimated that biological applications could generate USD 2–4 trillion in direct annual global economic impact in 2030–40. The opportunity is broad, but the number does not tell you where to act. Effective strategy identifies what your organisation can test now, learn from and scale—rather than waiting for a perfect plan.
Support can include
- Genomics and AI strategy
- Biotechnology market positioning
- Future-scenario development
- Product, platform and narrative strategy
- Go-to-market strategy, competitor analysis and product roadmap
- Ethical and societal risk mapping
- Scientific storytelling and communication strategy
- Stakeholder briefings for leadership teams
- Strategic review of emerging opportunities
What colleagues and collaborators say
Excerpts from LinkedIn recommendations.
“She is able to support highly demanding projects and turn them around at short notice, delivering very high quality, bespoke collateral, deeply suited to client / stakeholder needs.”
“Magdalena truly excelled in adapting to agile methodologies, quickly embracing the approach and significantly enhancing our team's efficiency and productivity.”
Where does your strategy need to lead?
Book a meeting to discuss your priorities, constraints and the change you want to achieve. We can shape an engagement around the decisions and delivery ahead.